{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-001330","form_type":"8-K","ticker":"HURA","cik":"0001498382","company_name":"TuHURA Biosciences, Inc./NV","filed_at":"2025-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.793629+00:00","generated_at":"2026-05-28T13:57:16.001746+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"TuHURA dismisses Marcum as auditor, appoints Cherry Bekaert after merger","bullets":["Marcum dismissed as independent auditor effective Dec 31, 2024; Audit Committee approved Dec 27, 2024.","No disagreements or reportable events with Marcum in past two fiscal years; going concern note in prior reports.","Cherry Bekaert appointed as new auditor for fiscal year ending Dec 31, 2024, effective Dec 27, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-001330","json":"https://secwatch.observer/filing/0000950170-25-001330.json","markdown":"https://secwatch.observer/filing/0000950170-25-001330.md","text":"https://secwatch.observer/filing/0000950170-25-001330.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1498382/000095017025001330/0000950170-25-001330-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1498382/000095017025001330/hura-20241227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T13:57:16.001746+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"218a653e1eecf69f5f106228986caa1fd4ba069b","claim":"TuHURA Biosciences, Inc./NV engaged Cherry Bekaert LLP as its auditor.","evidence_excerpt":"On December 27, 2024, following the completion of the Merger, the Audit Committee of the Company’s board of directors unanimously approved the appointment of Cherry Bekaert as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2024.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1498382/000095017025001330/0000950170-25-001330-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Cherry Bekaert LLP"}]},{"claim_id":"3b6c339fe51f3a2b32d8fbd0db48e93931365b40","claim":"TuHURA Biosciences, Inc./NV dismissed Marcum LLP as its auditor.","evidence_excerpt":"On December 31, 2024, as a result of completion of the Merger, Marcum was informed that it was dismissed as the Company’s independent registered public accounting firm.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1498382/000095017025001330/0000950170-25-001330-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"Marcum LLP"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}